Articolo del Prof. Gambacorti Passerini Carlo: Lancet Oncol 2008; 9: 600
Clinical Research Unit, University of Milano Bicocca, San Gerardo Hospital, Monza, Italy
(C Gambacorti-Passerini MD)
Correspondence to: Prof Carlo Gambacorti-Passerini
Part I: Milestones in personalised medicine—trastuzumab will be published in July 2008.
(C Gambacorti-Passerini MD)
Correspondence to: Prof Carlo Gambacorti-Passerini